The launched products are Piperacillin/Tazobactam — with a unique patented manufacturing technique — and Daptomycin, which launches in Egypt for the first time.
Sandoz’s new probtioic — ‘Linex’ – with Bifidobacterium lactis BB-12 supports the balance and function of useful intestinal microflora.
Compared to 1990, musculoskeletal disorder worldwide prevalence has risen by 45%1
The virtual launch was held over the course of two days, with the first day addressing nephrologists under the patronage of the Egyptian Society of Nephrology and Transplantation. The second day reached to address hepatologists from across the country.
